-
SOTIO’s DCVAC/LuCa Significantly Improves Survival in Patients with Stage IV Non-small Cell Lung Cancer
b3cnewswire
June 03, 2019
SOTIO’s DCVAC/LuCa Significantly Improves Survival in Patients with Stage IV Non-small Cell Lung Cancer.
-
Experts Develop Standardized Tool for Describing Cell Therapies
drugs
May 31, 2019
Experts develop standardized tool for describing cell therapies.
-
It's Never Too Late for New Brain Cells
drugs
May 30, 2019
It's Never Too Late for New Brain Cells.
-
Vineti Opens New Regional HQ in Maryland
contractpharma
May 29, 2019
New office expansion further enables accelerated cell and gene therapy clinical development and commercial operations in the Eastern United States.
-
ProBioGen and Abcuro Signed GlymaxX®-Improved Cell Line Development and GMP Production Agreement
b3cnewswire
May 24, 2019
ProBioGen and Abcuro Signed GlymaxX®-Improved Cell Line Development and GMP Production Agreement
-
Avelumab + Axitinib Approved for Treatment of Renal Cell Carcinoma
drugs
May 17, 2019
Avelumab + Axitinib Approved for Treatment of Renal Cell Carcinoma.
-
ProBioGen, Vaccitech Ink Cell Line License Agreement
contractpharma
May 16, 2019
Will leverage ProBioGen’s AGE1.CR duck cell technology for large-scale manufacturing.
-
Bone cells suppress cancer metastases
worldpharmanews
May 15, 2019
Bone cells suppress cancer metastases.
-
Bayer Invests $150M to Build Cell Culture Technology Center
contractpharma
May 10, 2019
Bayer is investing $150 million in its Berkeley, CA pharmaceutical development and manufacturing site to build a Cell Culture Technology Center for the development of biological therapies.
-
Rainin TerraRack™ benefits cell differentiation studies
europeanpharmaceuticalreview
May 07, 2019
Rainin TerraRack™ benefits cell differentiation studies.